Witryna7 paź 2009 · In its IMS Market Prognosis report, the firm forecasted market growth of 4% to 6% on a constant dollar basis next year, exceeding $825 billion, with an expansion of up to 7% through 2013,... WitrynaPricing reforms and rising generic usage will rule out growth in the overall value of the Japanese pharmaceutical market, which is expected to decline at a CAGR of 0.6% in the five years to 2024.
Africa: A ripe opportunity - Fuller Treacy Money
Witryna11 kwi 2024 · April 11th, 2024, 11:07 AM PDT. Tom Keene, Jonathan Ferro and Lisa Abramowicz have the economy and the markets "under surveillance" as they cover the latest in finance, economics and investment ... WitrynaPharmerging markets’ spending will grow primarily from increased use of medicines while China, the leading pharmerging country, will reach $160-190 billion in spending with slowing growth to 2024. Global Use of Medicines in 2024. Report by the IMS Institute for Healthcare Informatics. Page 1 fEXECUTIVE SUMMARY Transformations in disease … hillcroft st houston tx
IMS World Review PDF Euro Retail - Scribd
Witryna1 lis 2015 · Deal Trends in Diabetes The Deal Trends in Diabetes report from IMS Health’s PharmaDeals analyses 500+ diabetes deals from 2009 to 2014 and provides … WitrynaEach IMS ® World Review Executive report provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analyses for different five-year periods, including the breakdown of sales by regions, … Witrynaims forecast: $1.2 trillion market by 2016 Rebound in Global Medicine Spending Robust demand in pharmerging markets – where annual spending will nearly double by 2016 – and a more modest uptick in developed economies are poised to drive global growth over the next five years, says an IMS Institute for Healthcare Informatics report. smart coworking